How many samples are needed to infer truly clonal mutations from heterogenous tumours?

Modern cancer treatment strategies aim to target tumour specific genetic (or epigenetic) alterations. Treatment response improves if these alterations are clonal, i.e. present in all cancer cells within tumours.